{
    "Trade/Device Name(s)": [
        "Chloride Electrode Gen. 2",
        "COBAS INTEGRA Chloride Electrode Gen. 2"
    ],
    "Submitter Information": "Roche Diagnostics Corporation",
    "510(k) Number": "K060108",
    "Predicate Device Reference 510(k) Number(s)": [
        "K963627"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGZ"
    ],
    "Summary Letter Date": "February 16, 2006",
    "Summary Letter Received Date": "January 27, 2006",
    "Submission Date": "January 12, 2006",
    "Regulation Number(s)": [
        "21CFR862.1170"
    ],
    "Regulation Name(s)": [
        "Chloride test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Sodium",
        "Potassium",
        "Chloride",
        "Lithium"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "COBAS INTEGRA systems"
    ],
    "Method(s)/Technology(ies)": [
        "Ion-selective electrode"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Electrode"
    ],
    "Document Summary": "FDA 510(k) summary for COBAS INTEGRA Chloride Electrode Gen. 2 for quantitative determination of sodium, potassium, chloride, and lithium in serum, plasma, and urine using ion-selective electrodes",
    "Indications for Use Summary": "Intended for quantitative determination of sodium, potassium, chloride in serum, plasma and urine, and lithium in serum and plasma; recommended for plasma sample analysis and may be used with serum and urine samples for diagnosis and treatment of electrolyte and metabolic disorders",
    "fda_folder": "Clinical Chemistry"
}